S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Achillion Shares Rise, Regulus Falls After Hepatitis C Results (2015/2/9)|
|Hopes for single-dose Hepatitis C drug fade (2015/2/9)|
|Regulus Therapeutics Inc. (Nasdaq: RGLS) to Ring The Nasdaq Stock Market Closing Bell (2015/2/9)|
|Regulus Announces Key Goals Under its 'Clinical Map Initiative' for 2015 (2015/1/8)|
|Regulus Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights (2015/2/18)|
|Regulus to Present at 2015 RBC Capital Markets' Healthcare Conference (2015/2/19)|
|Regulus Announces Timing for Fourth Quarter and Year-End 2014 Financial Results Webcast and Conference Call (2015/2/12)|
|Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis (2015/2/2)|
|Regulus to Present at Two Upcoming Investor Conferences (2015/2/2)|
|All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57 (2015/2/9)|
Click above to view more mutual fund data and stats for rgls - Regulus Therapeutics Inc.